erlotinib 25 MG Oral Tablet
- RxCUI
- 603208
- RxNorm name
- erlotinib 25 MG Oral Tablet
- Display name
- erlotinib 25 MG Oral Tablet
- Full name
- erlotinib 25 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erlotinib | ERLOTINIB | Zydus Lifesciences Limited | daaa1329-3a3f-439c-b13d-b301daa234d4 | 2024-11-28 | 603208 | |
| ERLOTINIB | ERLOTINIB | Camber Pharmaceuticals, Inc. | a3b2d622-b4d5-4819-862b-f8fd3adcec6f | 2024-06-26 | Warnings, Adverse reactions | 603208 |
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | Alembic Pharmaceuticals Limited | ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b | 2024-06-10 | Warnings, Adverse reactions | 603208 |
| Erlotinib | ERLOTINIB | Zydus Pharmaceuticals USA Inc. | c35e019d-ec34-4e61-9400-a7ae7913e025 | 2023-10-05 | Warnings, Adverse reactions | 603208 |
| ERLOTINIB HYDROCHLORIDE | ERLOTINIB HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | ccf1e415-4980-462f-8ac2-87979bda149e | 2023-02-17 | Warnings, Adverse reactions | 603208 |
| Erlotinib | ERLOTINIB | Aurobindo Pharma Limited | 3ecafc1e-979a-4aff-a276-18fc0b110491 | 2022-06-06 | Warnings, Adverse reactions | 603208 |
| Erlotinib | ERLOTINIB | Teva Pharmaceuticals USA, Inc. | 5d97f401-4853-4a9a-907d-21e8a4d16088 | 2021-03-17 | Warnings, Adverse reactions | 603208 |
| Erlotinib Hydrochloride | ERLOTINIB HYDROCHLORIDE | Novadoz Pharmaceuticals LLC | 4cff04f5-3693-4d87-a9f8-a2b195e3d26e | 2019-12-03 | Warnings, Adverse reactions | 603208 |
| Erlotinib | ERLOTINIB | Sun Pharmaceutical Industries, Inc. | e36fa076-e23b-437f-bbd2-0433ce333175 | 2019-11-06 | Warnings, Adverse reactions | 603208 |
| Erlotinib | ERLOTINIB HYDROCHLORIDE | Armas Pharmaceuticals Inc. | 53cf8868-cfd8-4c6e-ad9d-3171ff1e4d8c | 2019-10-25 | Warnings, Adverse reactions | 603208 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 5d97f401-4853-4a9a-907d-21e8a4d16088 | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 7 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20210317 |
| ccf1e415-4980-462f-8ac2-87979bda149e | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 4 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20230217 |
| daaa1329-3a3f-439c-b13d-b301daa234d4 | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 3 | Erlotinib Tablets | 20241128 |
| ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20240610 |
| c35e019d-ec34-4e61-9400-a7ae7913e025 | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20231005 |
| e36fa076-e23b-437f-bbd2-0433ce333175 | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 3 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20191106 |
| a3b2d622-b4d5-4819-862b-f8fd3adcec6f | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20240626 |
| 3ecafc1e-979a-4aff-a276-18fc0b110491 | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20220606 |
| 4cff04f5-3693-4d87-a9f8-a2b195e3d26e | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20191203 |
| 53cf8868-cfd8-4c6e-ad9d-3171ff1e4d8c | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use ERLOTINIB TABLETS safely and effectively. See full prescribing information for ERLOTINIB TABLETS. ERLOTINIB tablets, for oral use Initial U.S. Approval: 2004 | 20191025 |
| 5783976b-0862-44e5-9b19-0f41d236d5c3 | erlotinib 25 MG Oral Tablet [PSN] · erlotinib 25 MG Oral Tablet [SCD] · erlotinib (as erlotinib hydrochloride) 25 MG Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use TARCEVA safely and effectively. See full prescribing information for TARCEVA. TARCEVA (erlotinib hydrochloride) tablet for oral use Initial U.S. Approval: 2004 | 20120105 |